Keio University

Press Release

1151-1160 items (total 1560)
Published At November 15, 2019

iPS Cell Research Discovers Common Pathologies in Psychiatric Disorders Elucidation of the Pathogenesis of Bipolar Disorder and Schizophrenia May Find Application in Therapeutic Drug Development

Published At November 13, 2019

Special T Cells Found in Supercentenarians Over 110 Years of Age—Single-Cell Level Analysis of Immune Cells in Supercentenarians

Published At November 12, 2019

The 709th Mita Public Speaking Event (November 26): "The Power of Genes and the Environment in Child Development" by Dr. Takao Takahashi (Professor, Department of Pediatrics, Keio University School of Medicine)

Published At November 07, 2019

Potential for Realizing Next-Generation Nutritional Therapy Targeting the Metabolic Preferences of Gut Microbiota—Suppressing the Growth of Potentially Pathogenic Bacteria in the Inflamed Gut by Controlling Dietary Amino Acids

Published At November 01, 2019

Keio University and Taisho Pharmaceutical Co., Ltd. Begin Joint Research on a Recovery Program for Athletes

Published At October 31, 2019

Dietary Habits Found to Have No Association with Adolescent Idiopathic Scoliosis—A Detailed Lifestyle Survey of Female Junior High School Students—

Published At October 30, 2019

Discovery of a Novel Nucleus Where Multiple Brain Monoamines Accumulate—Expected to Improve Understanding of Mood Disorders—

Published At October 29, 2019

Maximizing the Performance of Spintronics Devices: Toward the Development of Next-Generation, Energy-Saving Electronic Technology Based on Electron Spin

Published At October 25, 2019

Successful Generation of Human Hepatic Progenitor Cells: A Team from Tokyo Medical University and Keio University Establishes a Key Technology for New Treatment Strategies for Liver Disease

Published At October 24, 2019

Discovery of Common Pathophysiology in Psychiatric Disorders Through Research Using iPS Cells—Expected to Contribute to Elucidating the Pathophysiology of Bipolar Disorder and Schizophrenia and the Development of Therapeutic Drugs—